FOLH1 and prostate neoplasm: This finding is consistent with that reported by a retrospective cohort study involving 194 patients who underwent 18F-PSMA-1007 PET/CT [20], which indicated a significant correlation between a higher SUVmax of the primary prostate tumor and rising PSA levels.